In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients
Sign Up to like & getrecommendations! Published in 2021 at "Haemophilia"
DOI: 10.1111/hae.14452
Abstract: Heparin management in hemophilia A (HA) patients with a factor VIII (FVIII) inhibitor can be challenging due to severe activated clotting time (ACT) prolongations. It is important to better understand the impact of emicizumab, a… read more here.
Keywords: emicizumab activated; vitro effects; activated clotting; clotting time ... See more keywords